Back

Circulating dipeptidyl peptidase 3 levels in acute heart failure: insights from the PUSH-AHF trial

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Enhanced aspects of clinical care Biomarkers Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Mr Stijn Legtenberg

University Medical Centre Groningen, Groningen (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Factors associated with NT-proBNP reduction in acute heart failure: a secondary analysis of the PREMIER trial
Doctor Y. Nabeshima (Saga, JP)
Abstract
Presentation thumbnail
Long term follow-up of autosomal recessive atrial dilated cardiomyopathy associated with mutation of natriuretic peptide precursor A
Doctor M. Iseppi (Trento, IT)
Abstract
Presentation thumbnail
Operational characteristics of a clinical algorithm to optimize the detection of undiagnosed heart failure in primary care: insights from a prospective, multicenter study
Professor S. Stewart (Fremantle, AU)
Abstract
Presentation thumbnail
Artificial intelligence-enabled electrocardiography for identifying heart failure in patients with dyspnea in the emergency department
Associate Professor J. Park (Seongnam, KR)
Abstract
Presentation thumbnail
AI-enabled ECG imaging for the detection of cardiac amyloidosis across amyloidosis subtypes
Miss A. Achten (Maastricht, NL)
Abstract

Access the full session

Session thumbnail
Enhanced aspects of clinical care

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on current state of the diagnosis of heart failure
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Session
From genetic signatures to clinical implications

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources